Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,608.50
Bid: 1,608.50
Ask: 1,609.00
Change: 8.50 (0.53%)
Spread: 0.50 (0.031%)
Open: 1,608.00
High: 1,616.00
Low: 1,604.50
Prev. Close: 1,600.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Astrazeneca leads FTSE higher on bid speculation

Thu, 21st Aug 2014 17:42

- Healthcare stocks lift FTSE- German PMI data drives sentiment- Investors look ahead to Draghi speech- UK retail sales disappointtechMARK 2,819.77 +0.82%FTSE 100 6,777.66 +0.33%FTSE 250 15,838.57 +0.57%London's blue chips ended Thursday's session on a positive note, led by Astrazeneca. Increased speculation regarding ECB action, on the heels of weaker than forecast readings on the Eurozone economy, were offset by a weak report on UK retail sales. After making gains both early and late on, the FTSE 100 ultimately closed 22 points higher at 6,778. July saw UK retail sales register their slowest annual gain since November, with volumes surprising with a slowdown to just a 0.1% rate of gain, compared to an advance of 0.2% in June. Expectations had been for a rise of 0.4%. Investors were also surprised to see that food sales declined, the first time on record that this has happened. The Office for National Statistics also released figures showing that while UK public finances improved last month borrowing still remained above the government's target.Across the Channel, Markit's 'flash' composite Purchasing Managers' Index (PMI), which tracks growth in the manufacturing and service sectors that make up more than two-thirds of the economy, fell to 54.9 in August from 55.7. However, it nonetheless remained well above the crucial 50 mark that separates growth from contraction.On the upside, Germany's private sector grew for a 16th month running in August, suggesting Europe's largest economy could expand robustly in the third quarter after it suffered a surprise contraction in the second.However, following those figures Barclays Research pointed out that it sees "material downside risks" to its forecast for the Eurozone's GDP to expand at 0.3% quarter-on-quarter clip in the third quarter. Meanwhile, the Jackson Hole Symposium of central bankers is due to kick off later Stateside with comments from policymakers around the world likely to be closely watched.Bid speculation sends Astrazeneca racing aheadHealthcare stocks gained strongly amid speculation Pfizer may make another bid for Astrazeneca. Smith & Nephew and GlaxoSmithKline also rose strongly. Financial stocks also made decent gains, with Hargreaves Lansdown, Standard Life, Old Mutual and Aviva all higher. Mining stocks led to the downside after metals consumer China disappointed with its manufacturing data and metals prices fell. Fresnillo, Randgold Resources, Anglo American, Rio Tinto and BHP Billiton all fell into the red. BHP was still under pressure in the aftermath of Tuesday's underwhelming plans for a demerger. Chief financial officer Graham Kerr, who is due to be the head of the spin-off company, has been cited as saying that the lack of a share buyback - which many investors had been expecting - was a "sore point", while plans to give shareholders stock in the new firm may have "irritated" some who are not mandated to hold investments in Australia. Oil stock Tullow Oil was also in the red. On the second tier, metal miner Kazakhmys hailed progress with a shake-up designed to focus it on the lucrative copper market, but said 2014 gold production was likely to fall short of hopes, pushing the stock into the red. Investec knocked Ophir Energy lower after it reduced its rating to 'hold' from 'buy' and lowered its target price to 250p from 315p.FTSE 100 - RisersAstraZeneca (AZN) 4,411.50p +2.95%Schroders (SDR) 2,392.00p +2.66%Hargreaves Lansdown (HL.) 1,133.00p +2.16%CRH (CRH) 1,401.00p +2.04%Barratt Developments (BDEV) 366.20p +1.84%Smith & Nephew (SN.) 1,064.00p +1.62%3i Group (III) 387.60p +1.57%Standard Life (SL.) 376.90p +1.48%Mondi (MNDI) 1,018.00p +1.39%Rolls-Royce Holdings (RR.) 1,037.00p +1.37%FTSE 100 - FallersFresnillo (FRES) 938.00p -3.55%Randgold Resources Ltd. (RRS) 4,904.00p -1.86%Kingfisher (KGF) 306.80p -1.67%Anglo American (AAL) 1,573.50p -1.29%Antofagasta (ANTO) 808.50p -1.28%Royal Mail (RMG) 440.30p -1.21%Petrofac Ltd. (PFC) 1,126.00p -1.14%easyJet (EZJ) 1,324.00p -1.12%Aberdeen Asset Management (ADN) 431.70p -1.10%Rio Tinto (RIO) 3,433.00p -0.72%FTSE 250 - RisersSenior (SNR) 292.40p +3.84%Hikma Pharmaceuticals (HIK) 1,742.00p +2.96%Ocado Group (OCDO) 377.90p +2.89%Phoenix Group Holdings (DI) (PHNX) 735.50p +2.87%RPS Group (RPS) 269.50p +2.86%Cranswick (CWK) 1,349.00p +2.82%International Personal Finance (IPF) 520.00p +2.77%Diploma (DPLM) 686.00p +2.62%Spirent Communications (SPT) 103.50p +2.48%Carillion (CLLN) 337.60p +2.30%FTSE 250 - FallersKazakhmys (KAZ) 291.10p -5.64%Petra Diamonds Ltd.(DI) (PDL) 183.60p -3.72%Ophir Energy (OPHR) 221.40p -3.61%Exova Group (EXO) 220.00p -3.51%Just Retirement Group (JRG) 146.20p -2.60%Thomas Cook Group (TCG) 121.00p -2.42%Electrocomponents (ECM) 239.80p -2.36%Ladbrokes (LAD) 132.30p -2.22%Lonmin (LMI) 212.90p -2.11%African Barrick Gold (ABG) 239.60p -1.80%AB
More News
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more
9 Jan 2024 08:03

TOP NEWS: GSK to buy Aiolos Bio for up to USD1.4 billion

(Alliance News) - GSK PLC on Tuesday said it will acquire asthma drug developer Aiolos Bio Inc for USD1 billion upfront, as well as up to USD400 million in certain success-based milestone payments.

Read more
9 Jan 2024 07:16

GSK buys respiratory drug maker Aiolos for $1bn

(Sharecast News) - GSK said it was buying Aiolos, a clinical-stage biopharmaceutical company focused on treatment of respiratory and inflammatory conditions, for up to $1.4bn (£1.1bn).

Read more
8 Jan 2024 23:39

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 23:00

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 19:02

Moderna says it hit its 2023 COVID vaccine sales goal

Jan 8 (Reuters) - Moderna on Monday said its 2023 COVID vaccine sales would be around $6.7 billion, coming in above the lower end of its full-year forecast, and reiterated its goal of returning to sales growth in 2025.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.